Posts Tagged ‘venture capital’
-
November 10th, 2009
Commercialising New Uses for Gold
Today World Gold Council announces new strategic initiatives to develop the long-term industrial markets for gold. WGC will co-invest with venture firms to accelerate the development and commercialisation of gold-based innovative technologies. Through its new Innovation Partnerships, WGC will support industrial partners engaged in the development of new practical applications for gold.
We believe that our unrivalled knowledge of the industrial uses for gold puts us in a unique position to help facilitate and accelerate commercialisation of gold-based innovations. As I explained in the press release, both the Innovation Partnership programme and our increasing engagement with the early-stage venture community will help ensure that promising gold-research currently emerging from university labs has the best possible chance of quickly reaching the market place and being commercialised.
If you are interested in collaborating with World Gold Council please let us know.
-
May 26th, 2009
Progress for prototype meningococcal testing device
A prototype meningococcal testing device that was featured in NanoTech Gold News has received investment and support from New Zealand biotechnology firm Trinity Diagnostics. According to co-partner NanoVentures Australia:
The Agreement, signed on 27th April 2009, provides Trinity Diagnostics with an exclusive license to the technology, and commits Trinity to invest in the laboratory verification of the diagnostic system. If this phase is successful, the parties will enter into a full development agreement funded by Trinity and its investors. It is anticipated that the pre-clinical program will take around two years.
The incidence of death and disability resulting from meningococcal disease may be significantly reduced by rapid diagnosis, enabling antibiotic treatment at an earlier stage of disease progression. Currently available tests take between 2 and 48 hours to provide a result, and often involve culturing either blood or cerebrospinal fluid to detect the presence of meningococcal bacteria.
The new diagnostic test has been developed by Quintain NS, a subsidiary of NVA. The Quintain NS meningococcal test is based on nanoparticle and nanocluster technology developed at RMIT University, one of Australia’s leading bioengineering centres. Nanoparticles of gold are covered with antibodies that attract the meningococcal bacteria. In the presence of the bacteria, the gold particles ‘cluster’ together, which provides a simple and rapid means of detection for the disease. Preliminary testing under laboratory conditions has indicated that a diagnosis can be returned in 15 minutes.
This is another great example of how gold nano materials are becoming increasingly important in the medical diagnostic market.
The prototype device featured in NanoTech Gold News
Richard Holliday
Recent comments: